Press Releases
-
7 May, 2026Spago Nanomedical interim report January-March 2026
-
6 May, 2026Spago Nanomedical’s phase I/IIa study Tumorad-01 meets a primary endpoint and provides further visible tumor uptake
-
24 Mar, 2026Spago Nanomedical’s abstract on Tumorad® accepted for presentation at radiopharma conference
-
17 Mar, 2026Spago Nanomedical continues recruitment in the phase I/IIa Tumorad-01 study following positive DMC recommendation
-
10 Mar, 2026Spago Nanomedical strengthens CMC and supply capabilities to support next phase of Tumorad development